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“Global burden of trichiasis in women as 
compared to men: Findings from the Global 




The secondary analysis undertaken for this MPH dissertation examines the global 
prevalence of trichiasis in relation to gender in trachoma endemic countries. 
Part A is the research protocol which outlines the background and the process of this 
research. This study is a population-based analytical study using data from the Global 
Trachoma Mapping Project (GTMP). GTMP was a standardized population-based trachoma 
prevalence survey undertaken to provide trachoma prevalence estimates. GTMP data was 
collected using the World Health Organisation–recommended population based prevalence 
survey methodology. Trachoma suspect district were identified for inclusion and multi-
stage random sampling was used to sample households for examination of residents for 
clinical trachoma.  
Part B presents the background and highlights the importance of this research by 
exploring the existing theoretical and empirical literature relevant to the topic. It describes 
how trachoma is transmitted, its clinical manifestations, and the way it can lead to 
blindness. Results from previous studies on gender and trichiasis are presented.    
Part C presents the research project in a format suitable for journal submission. The 
background of this research project is summarized and the meta-analysis is conducted at 
the global level, at the country level, the regional level, the state level and at the EU level 
but all in accordance to prevalence of trichiasis in the EUs. The implications of the findings 
are discussed and limitations in interpretation presented. 
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Title: Global burden of trichiasis in women as compared to men: Findings from the Global 
Trachoma Mapping Project 
Trichiasis, whether caused by trachoma or any other cause is the seventh leading cause of 
blindness in the world. There have been many studies determining the prevalence of 
trichiasis by age and sex and there has been one systematic review of gender and trichiasis. 
The systematic review, undertaken in 2009 only includes data from a few surveys in a few 
countries, where such data was available.  It was not possible to undertake any sub-
analyses nor was it possible to assess factors which might predict inequity.  It has been 
suggested that women, as the primary care-givers of children (the primary reservoir of 
infection) have a higher risk of being re-infected with trachoma than men.  
We hypothesize that women have an excess prevalence of trichiasis compared to men and 
that this association is also linked to whether the prevalence of the disease in the 
population, in particular, that when the prevalence of trichiasis is high, the female excess is 
high while when the prevalence of trichiasis is low, there is little excess of trichiasis in 
women.  The aim of this study is to use the large GTMP data set to establish the patterns 
and trends of the association between gender and trichiasis.   
 
Design: Population-based Analytical study. 
Population: All countries in the Global Trachoma Mapping Project that agree to share data 
Sites:  Global 
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Instrument & Methods: This thesis will use existing national authorized GTMP data for 
secondary analysis 
Purpose and objectives of the study 
The overall purpose of this study is to determine the global burden of trichiasis in women 
as compared to men. The primary objectives of the study are to assess if the ratio of 
trichiasis in women to men varies by prevalence of trichiasis and if the ratio is the same in 
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Definition of terms 
 
CO:  Corneal Opacity 
CSC:   Cataract Surgical Coverage 
GET2020: Global Elimination of Trachoma by 2020 
GTMP: Global Trachoma Mapping Project 
SAFE: Surgery, Antibiotics, Facial wash and Environmental Cleanliness 
TF:  Trachomatous Inflammation: Follicular 
TI:   Trachomatous Inflammation: Intense 
TRA:  Trachoma Rapid Assessment 
TS:  Trachomatous Scarring  
TT:   Trachomatous trichiasis 
UCT:  University of Cape Town 
VI:   Visual Impairment 
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CI:   confidence interval 






Trachoma; [MESH], Trichiasis; Chlamydia: Trachomatis; 
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Background to the research 
 
Blindness is a major global public health concern. An age adjusted systematic review from 
1990 to 2010 revealed that globally 32 .4 million people (95% CI: 29.4 – 36.5 million 
people) were blind. In this study blindness was defined as a vision in the better eye of 
<3/60. (Bourne, R., et al 2013: 39)This represented 0.5% (95% CI: 0.4 – 0.5) of the global 
population). In the same study it was estimated that 191 million people (95% CI: 99 – 13 
million people) had moderate and severe visual impairment (defined as a vision in the 
better eye of 3/60 to 6/24) which represented 2.8% of the global population (2.5% – 
3.5%). There is strong evidence of an age-adjusted excess burden of blindness in women as 
compared to men. Eighteen years ago, it was revealed that blindness, adjusted for age, was 
40% more in women as compared to men. (Abou-Gareeb, I, et al., 2001; 39 - 56). In Africa 
there was a 43% (95% CI 33% – 53%) excess burden of blindness in women compared to 
men.  Findings were similar in Africa Asia (OR 1.41 95% CI 1.29 – 1.54) and in 
industrialised countries OR 1.63, (95% CI: 1.30 - 2.05) (Mganga, H, Lewallen, S. & 
Courtright, P, 2011: 101), however the interpretation of the findings from industrialized 
countries is limited by the inability to adjust for age in the oldest age groups. The excess 
burden of blindness in women was also observed in population-based surveys in Oman 
during 1996−1997; in these settings women and men had an age-adjusted prevalence of 
blindness of 1.4% and 0.8% respectively, giving women a 1.89-fold (95% CI, 1.55−2.51) 
higher prevalence of blindness compared to men.(khandekar, 2002)Similar findings were 
evident for visual impairment, table 1 below; 
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Table 1: Prevalence of visual impairment in men and women by age group (Stevens, G.A, et 
al. 2013: 120(12) 2377- 2384). 
 
Age group Prevalence of visual impairment (95% CI) 
 Males Females 
0-49 years 0.08 (0.07-0.09) 0.10 (0.09-0.12) 
50-69 years 0.85 (0.74-0.97) 1.1 (1.0-1.3) 
70+ years 4.2 (3.7-4.8) 5.3 (4.8-6.0) 
   
The Oman researchers found that men (with cataract) were 1.55-fold (95% CI 1.50−1.60) 
more likely to have received cataract surgery compared to women. (Khandekar, R, & 
Mohammed, A.J, 2007; 267-272). These findings are similar to the global estimates from a 
systematic review and Meta – analysis of 23 population based surveys of cataract surgical 
coverage (CSC); in this review 21 of the 23 surveys showed a higher CSC in men.(Mousa, S, 
et al., 2009: 298).Men were 1.71 times (95% CI: 1.48 – 1.97) more likely to have had 
cataract surgery than women.  In the Oman 1997 and 2005 surveys a 29.3% reduction in 
blindness was detected, but women continued to have a statistically higher prevalence of 
blindness (9.93% among 40+ age) compared to men (6.59% among 40+ age)(khandekar, R 
&Mohammed, A. F 2007;267 - 272) 
The word “trachoma”, was first used in Graeco Roman times. It comes from the Greek word 
“rough” which describes the surface appearances of the conjunctiva in chronic trachoma. 
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(Sandford-Smith, J, 1990). Approximately 232 million people live in trachoma endemic 
areas and are at risk of infection. Trachoma infection spreads through personal contact 
(hands, clothing) and by flies that have been in contact with discharge from the eyes or 
nose of an infected person. (Mohammadpour, M et al., 2016: 169). The natural history of 
trachoma usually includes inflammation during childhood, with the formation of lymphoid 
follicles and diffuses infiltration with papillae in the conjunctiva. Chronic inflammation 
eventually results in conjunctival scars, which, in turn, may lead to trichiasis and corneal 
complications in older children and adults. The World Health Organisation (WHO) 
recommends a simple classification of trachoma including five clinical signs. (Thylefors et 
al., 1987: 483)  The primary sign of active trachoma, called trachomatous inflammation 
follicular (TF), is commonly found in children age less than five years. To be considered TF 
positive there must be five or more follicles (0.5 mm or greater) in the upper tarsal 
conjunctiva.  Follicles are round lumps or spots that are paler than the surrounding 
conjunctiva upon conjunctival examination.  The other sign of inflammation which is also 
common in children is called trachomatous inflammation intense [TI]. TI is defined as 
diffused redness caused by vascular tufts. Multiple episodes of TF and/or TI can lead to 
trachomatous scarring (TS). This is the presence of scarring in tarsal conjunctiva. Scars are 
easily visible as white lines, bands, or sheets (fibrosis) in the tarsal conjunctiva. Scarring of 
the conjunctiva can lead to trachomatous trichiasis (TT) this is when one or more eyelashes 
are touching the eye globe or evidence of epilation (eyelash removal).  The process of 
touching the cornea can lead to ulcers, which, when healed, become opacities.  Corneal 
opacities (CO) can reduce vision and lead to irreversible blindness. (Thylefors et al., 1987: 
483)   
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In 1998 WHO member states signed a Global Alliance for the Elimination of Blinding 
Trachoma by 2020 (GET 2020) through World Health Assembly resolution 51.1. This 
declaration called for the elimination of trachoma including requesting members to 
complete the mapping of trachoma and implementation of interventions to elimination 
trachoma. (GET 2020 resolution 51.1)   
 The WHO adopted the SAFE strategy, whereby S refers to surgery, the primary option of 
managing trachomatous trichiasis.  During trichiasis surgery, the eyelid is repositioned in a 
way that in-turned eyelashes no longer touch the globe.  “A” refers to antibiotic treatment 
of communities to treat infections and decrease transmission. .F refers to facial cleanliness 
and E refers to environmental improvement, both important to reduce transmission.  
(Thylefors et al., 1987: 483)   
 
In 2009 Cromwell and colleagues conducted a systematic review and Meta – analysis of 
population-based surveys of trichiasis to assess if women had a higher age-adjusted 
prevalence than men.  The results, using data from 12 countries revealed overall odds of 
trichiasis in women 1.82 (95% CI 1.61 – 2.07) times that of men.  Table 2 presents the data 
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Table 2: Findings from 2009 meta-analysis of trichiasis by gender 
Country Setting Year of 
survey 
Excess burden of trichiasis in 
women (OR, 95% CI) 
Brazil Bebedouro State 1992 1.50 (0.25 - 9.02) 
Ethiopia Dalocha District 2001 1.34 (0.51- 3.54 ) 
 Alaba District 2003 3.82 (2.36 – 6.19) 
 Damot Gale  2004 3.12 (1.79 – 5.45) 
 Tigray Region 2006 1.70 (1.14 – 2.54) 
 Amhara TCP 2009 2.81 (2.08 – 3.80) 
 Amhara TCP 2009 2.69 (1.51 – 4.79) 
Egypt Nile Delta 1989 1.31 (0.80 – 2.16) 
 Monofiya Governate 2001 1.64 (1.08 – 2.47) 
Gambia National Survey 1998 2.10 (1.41 – 3.14) 
Ghana National Survey 2009 1.92 (1.29 – 2.85) 
Morocco Ouarzazate 1992 1.95 (0.84 – 4.55) 
Myanmar Mandalay Division 2007 0.83 (0.40 – 1.73) 
Nigeria Kaita LGA 2001 2.14 (1.36 – 3.37) 
 Katsina State 2008 1.93 (1.53 – 2.43) 
 Yobe State 2008 1.52 (0.90 – 2.56) 
 Plateau and Nassarawa 
State 
2009 2.48 (1.47 – 4.19) 
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Oman National Survey 2007 1.50 (0.98 – 2.31) 
Sudan Southern Sudan 2005 1.27 (1.08 – 1.49) 
 Mankien District 2006 0.94 (0.72 – 1.21) 
 Ayon County 2008 1.61 (1.10 – 2.34) 
 Southern Sudan 2008 1.45 (1.06 – 1.97) 
Tanzania National Survey 2008 2.00 (1.83 – 2.19) 
Vietnam 12 Districts 2006 1.67 (1.55 – 1.80) 
 
After the pooling, it was revealed through the review that trichiasis was 1.82 more likely to 
be found in women than in men. Courtright P, and West S, revealed that the sex related 
excess of trichiasis was more environmental than biological. It was also noted through the 
same study that the excess burden of trichiasis in women could likely be due to reinfection 
in women during child care. (Courtright, P, & West, S.K, 2004: 2012 - 2016).  
Methodology 
Study design 
This is a population-based analytical study using existing Global Trachoma Mapping Project 
(GTMP) data (secondary data analysis). Letters were written to all the relevant national 
coordinators requesting authority to use baseline GTMP data. All data was compiled into 5 
year age groups for calculating age and sex specific prevalence figures.  Surveys were 
pooled by specific characteristics such as geographic location and age-sex TT prevalence 
(grouped).  Age adjusted odds ratio for female excess will be calculated for each survey 
evaluation unit.    For countries with large data sets (e.g., Ethiopia and Nigeria) geographic 
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variations within countries were explored and sub analysis conducted at regional and state 
level. The entire sub – analysis were based at EU level results. 
Characteristics of study population 
GTMP included data from 2.1 million people examined for clinical trachoma from 1469 
districts across 22 countries.  
Inclusion  
Only data from GTMP population-based prevalence surveys (PBPS) were considered for 
inclusion since they provide a prevalence estimate applicable to the population.  
Exclusion criteria 
We did not include in our analysis data that was collected through ‘Acceptance-based 
Sampling for Trachoma Rapid Assessment’ methodologies or from Trachoma Rapid 
Assessments as these methods are not population based and do not provide a prevalence 
estimate that can be generalised to the population. Impact survey data was also not  used 
as differences in utilization of surgical services between men and women may account for 
some or all variation in gender differences.    
Data Analysis 
All the GTMP data were collected electronically using Android smart phones with the 
LINKS app developed and maintained by the Task Force for Global Health, Atlanta, GA, USA. 
Data are geo-referenced using global positioning system coordinates; they are then 
transmitted to a high security server for cleaning and approval by the relevant Ministry of 
Health (using a site-specific password-protected web interface). During our analysis, data 
was kept in a personal computer which has a password and the personal computer which 
is only accessed by the author. The GTMP dataset provided by the relevant Ministries of 
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Health was stored in a personal UCT student account which is protected and only 
accessible by the author.  
Statistical analysis has been conducted using Stata (13.0) statistical software (Stata Corp., 
College Station, TX, USA). Data from all the included studies including data on age, gender 
and the presence or absence of signs of trachoma at an individual level were pooled and the 
OR of the overall effect estimate were calculated using logistic regression in Stata. Revman 
V5.3 was used to come up with the pooled overall M-H odds ratios for results of different 
units. Owing to  heterogeneity between the studies as a result of the underlying differences 
in geographical location, cultural context, and possibly the underlying prevalence of 
trichiasis, a random effects model were used to weight the studies in the summary statistic. 
Sub-group analyses included assessment of gender-excess at different levels of trichiasis 
prevalence as well as by units, regions countries in the world.   
Ethical Consideration 
 
Description of Risks and Benefits 
No risks of any kind were anticipated from this study as only secondary data were used for 
analysis. There was no contact or communication with study participants. 
Potential risks and discomforts 
No potential risks and discomfort as secondary data were used for this study. 
Potential benefits 
The results from this study will inform planners and implementers of trachoma elimination 
programme on how gender affects the prevalence of trichiasis to the gender-focused 
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activities can be implemented, if needed. The findings from this research will also be useful 
for trachoma-related NGOs and donors to advocate for additional resources.   
Informed Consent Process 
For the collection of the GTMP data, informed consent was provided by all participants.  
National ethical committees provided approval prior to survey work.  Informed consent 
was not needed for the secondary data analysis conducted.  All governments authorised the 
use of the data; if data was not released by a specified country no analysis was conducted. 
Through the letters written to different countries, the responsible governmental representatives 
made informed decisions on releasing the data. 
Withholding information 
No information about the aim of the study was withheld to the authorising countries. 
Privacy and Confidentiality 
Only electronic data were used in this study and were only accessed by the author. A 
password was used for accessing the data, the password only known to the author. 
Publication and use of results 
 
The results from this study can be used by national programme managers to focus efforts 
at specific population groups.  Findings will also be useful for global advocacy efforts. 
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Justification of the study  
 
Trichiasis is a serious sign of trachoma; if no intervention is undertaken, the patient is at 
risk of corneal opacity and blindness. The WHO estimates that there are about 3 million 
people in the world with trachomatous trichiasis.     
In the 2009 systematic review  24 studies from 12 countries met the criteria for inclusion; 
7 from Ethiopia, 4 each from Nigeria and Sudan, 2 from Egypt and one each from Brazil, 
Gambia, Ghana, Tanzania, Morocco, Oman and Myanmar. Because the number of surveys 
was small there was no opportunity to assess if there was any variation in the excess 
burden of trichiasis in women according to the baseline prevalence of trichiasis.  It is 
hypothesised that in low prevalence areas there is likely to be little gender excess as much 
of the trichiasis may not be to trachoma.   
It is against all this background that we proposed to use the large GTMP data sets to answer 
the questions: 
 What is the burden of trichiasis in women compared to men?  
 Does the ratio of women to men vary at difference prevalence of trichiasis?  
 Is the ratio the same in all trachoma endemic countries?  
The results from this study can be used by national programme managers to focus efforts 
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Literature Review 
 
Aim of this literature review 
The aim of this Literature review is to establish whether there is similarity in the 
prevalence of trachoma trichiasis in women and men living in different trachoma endemic 
areas of the world. The review will also establish if there are any trends of odds ratios for 
gender as the prevalence of trichiasis changes from low to high.  
The Study Question 
What is the burden of trachoma trichiasis (TT) in women compared to men? Does the ratio 
of women to men vary at difference prevalence of TT? Is the ratio the same in all trachoma 
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Literature search strategy 
Reference Year Country Men in % Women in % Ratio  
Women to 
men  





Alene G.D., and Abode S. 2000 Ethiopia 14/440=3.2% 16/552 = 2.8% 0.875 
Luna E.J., Medina N.H., Oliveira M.B., de Barros 
O.M., Vranjac A., Melle H.H., 
1992 Brazil 2/490=0.4% 3/490= 0.61% 1.53 
Regassa K., Teshome T., 2001 Ethiopia 7/170= 4.1% 11/190 = 5.79% 1.41 
Wodimu A., Bejiga A., 2003 Ethiopia 21/1909=1.1% 83/1976 = 4.2% 3.82 
Regassa K., Teshome T.,  2004 Ethiopia 17/405=4.2% 59450=13.1% 3.12 
Mesfin M.M., de la Camera J., Taleke I.G., 




Emerson P.M., Ngondi J., Birn E., Graves P.M., 




Ngondi J., Gebre T., Shargi E.B., Adam L., Eji G., 




Ngondi J., Gebre T., Shargi E.B., Adam L., 2009 Ethiopia 15/973=1.54% 54/1304=4.14% 2.69 
Courtright ., Sheppard J., Schacter J., Said M.E., 
Dawson C.R., 
1989 Egypt 45/79=56.97% 59/79=74.68% 1.31 
Dorin P.J., Faal H, Johnson GJ 1998 Gambia 38/251=1.85% 69/1771=3.90% 2.1 
Yayemain D., King J.D., Debra O.,  Emerson P.M., 




Negrel A.D.,Khazraj Y.C., Okaley O., 1992 Morocco 8/321=2.49% 18/370=4.86% 1.95 
Durkin S.r., Casso R.J., Newland H.S., Aung T.H., 






Rabio M.M., Alhasan M., Abiose A., 2001 Nigeria 26/1233=2.10
% 
75/1660=4.51% 2.15 
Jip N.F., King J.D.,Diallo M.O., Miri E.S., Hamza 




Mpyet C., Ogosh C., Goyo M., 2008 Nigeria 21/840=2.5% 47/1237=3.80% 1.52 
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We searched the major databases including PubMed, OBSCO, and web of knowledge. We 
supplemented the search using Google scholar and by scanning reference lists of potential 
Cromwell et al 2009 Nigeria 18/9220=0.20
% 
64/13218=0.48% 2.4 
Khandekar R., Mohammed A.J., 2007 Oman 3/990=3.23% 66/1360=4.85% 1.5 
Ngondi J., Onsatigo A., Adamu L., Matende I., 




Ngondi J., Olensempele F., Onsalinga A., 
Matende I.,Baba S., Reacher  M et al. 
2006 Sudan 112/559=2% 186/991=18.77% 0.94 
King J.D.,Ngondi J., Gatpan G., Lipidia B., 




Ngondi J., Reacher M.H.,Mathews F.E.,Brayne C, 




Moshiro C., Masesa D.E., masanja H., Mkocha 













Durkin R.S.,  Casso J.R., Newland S.H.,Aung 
T.H., Shein W.K., Muecke S.J., Slva D.,Aung T. 
2006 Myanma
r 
13/832=1.56% 16/1241=1.29% 0.83 
Arab Al E.G., Tawfik N., Gendey E.L.R., Anwar 




Khandekar R., Mohmmed A.J., 2005 Oman 32/990=3.23% 66/1369=4.82% 1.49 
Mpyet C., Ongoshi C., 2008  Nigeria 21 (2.5)% 4.7 (5.1)% 2.04 
Assefa T.,Argaw D., Foster A.,Schwartz E., 2001 Ethiopia 91/443=20.5% 79.46% 3.88 
Cevallos V., Whitcher P.J.,Melese M., Alemaebu 
W.,Yi E.,Chidambaram J.D., Lee S., Reddy H., 
Gaynor B.D.,Lietman M.T., Keenan J.D., 
2004 Ethiopia 18/36= 50% 83/112=74.1% 1.48 
Kalua K.,Chirwa T.,Kalilani L., Abbenyi S., 
Mukaka M.,Bailey R. 
2010 Malawi 3/1244=0.24% 1/1999=0.55% 2.29 
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papers. Table 1 below shows the results we found for trichiasis in women as compared to 
men in 36 different papers. 
 
 
Clinical and epidemiological aspect of trachoma 
Disease History 
The word “trachoma”, was first used in Graeco Roman times. It comes from the Greek word 
“rough” which describes the surface appearances of the conjunctiva in chronic trachoma. 
(Sandford-Smith, J,1990). Approximately 232 million people live in trachoma endemic 
areas and are at risk. In trachoma, infection spreads through personal contact (hands, 
clothing) and by flies that have been in contact with discharge from the eyes or nose of an 
infected person. (Hatch, T.P, Allan, I, & Pearce, J.H, 1984: 13 - 20) The World Health 
Organisation (WHO) recommends a simple classification of trachoma including five clinical 
signs. (Thylefors et al., 1987: 483) The natural history of trachoma usually includes 
inflammation during childhood, with the formation of lymphoid follicles and diffuses 
infiltration with papillae in the conjunctiva. 
Trachoma remains the leading infectious cause of blindness in the world, (Solomon, A.W, et 
al., 2015: 214 - 225) and still remains high in various regions of the world such as Asia, 
Africa and the Middle East. (Silva, M.B.A, et al., 2017:10)   
 
Microbiology and Pathogenesis 
Trachoma has a gradual way of causing blindness. The pathogenesis of infection and 
replication of the causative agent, Chlamydia trachomatis is shown in Figure 1.  Acute 
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trachoma (TF) and the potentially blinding sequelae, trachomatous trichiasis (TT) have 
been illustrated. (Solomon, A.W, et al., 2015: 214 – 225).    
 
Figure 1: Microbiology and pathogenesis of trachoma 
Chlamydial trachomatis exist in two forms; in its infectious form is the elementary body 
which is a metabolically inactive, spore- like structure which is taken by host cells by 
receptor- mediated endocytosis (Taylor, H, et al., 2014: 2142 – 2152).The life cycle of 
C.Trachomatis is 72 hours within which the elementary body are fully released and are free 
to attach to new cells. (Mabey, D.C, Solomon, A.W, & Foster, A, 2003: 223 – 229) (Hatch, T.P, 
Allan, I, & Pearce, J.H, 1984: 13 - 20) 
 When the cells of the cornea are examined through the microscope, the examination 
reveals epithelial keratitis, sub epithelial infiltrates and extent of the limbic vessels of the 
cornea. The inflammatory response to primary infection of the conjunctiva by Chlamydia 
trachomatis leads to a mild, self-limited frame conjunctivitis, called inclusion conjunctivitis 
(Silva, M.B.A, et al., 2017:10)  
There is a high chance of reinfection for those people living in trachoma endemic regions of 
the world. Repeated infections lead to a hypersensitive immune response to Chlamydia 
antigens, causing an inflammatory response becomes increasingly lush and leading to all 
those stages of trachoma (Solomon, A.W, et al., 2015: 214 – 225).  
Clinical Progression signs and Stages of trachoma 
Active trachoma is common in children under the age of 10 and repeated re infection by 
Chlamydia trachomatis causing TF can lead to scarring of the upper tarsal conjunctiva.  
Conjunctival scarring (TS) leads to deformation of the lid in which contraction of the 
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conjunctiva causes entropion (in turning of the upper eyelid) and trichiasis (eye lashes 
rubbing the cornea). (Thylefors et al., 1987: 483)   
Figure 2: Clinical progression signs of trachoma 
The process leading from TF to TS to trichiasis is gradual and trichiasis is uncommon in 
children.  Trichiasis can lead to abrasions on the cornea, a painful condition. If un-managed, 
these abrasions can become infected and corneal scarring can lead to blindness. (Taylor, H, 
et al., 2014: 2142 - 2152)  
Surgical management options are few when the disease has reached the stage of corneal 
opacity. Surgery may be undertaken in patients with corneal opacity simply to relieve pain 
rather than reverse blindness. (Burton, M.J, et al., 2006: 847) 
All these signs are not mutually exclusive; they may occur in the same patient and the same 
eye. (Solomon, A.W, et al., 2015: 214 – 225). Thus, during examination each should be 
assessed independently. For programme decision making, TF in children age 1-9 years is 
assessed.  TF is considered positive if there are at least five follicles of at least 0.5 mm 
diameter in the upper tarsal conjunctiva. Follicles are rounded elevations of the 
conjunctiva, bright and fainter than the conjunctiva around. They should be distinguished 
from changes caused by small scars and degenerative deposits in the conjunctiva. 
(Solomon, A.W, et al., 2015: 214 – 225).  
Epidemiology of Trachoma  
According to Silva and colleagues, trachoma remains endemic in many of the poorest and 
more remote areas of Africa, Asia, Australia, and the Middle East. The estimated number of 
people with trichiasis is about 3 million. WHO identifies 53 countries as being trachoma 
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endemic and estimates that 229 million people live in endemic areas, with most trachoma 
in Africa. (Silva, M.B.A, et al., 2017:10).    
 
http://www.ircwash.org/sites/default/fil 1 
Figure 3: Trachoma progression 
 
Active trachoma (TF) is most common in children younger than 5 years and the prevalence 
can reach 60% or more. (Courtright, P, et al., 1989: 536 – 540) The greatest load of 
infection is also in young children. (West, S.K, et al., 2015: 170 - 175) (The prevalence of 
active trachoma decreases with age and few adults have signs of active trachoma, and even 
fewer have evidence of infection. (Wright, H.R, Turner, A, &Taylor, H.R, 2008. 
37(9628):1945 – 1954) (Munoz, B, et al., 1999; 1167 – 1171) (Ngondi, J, et al., 
2005.83(12)904 – 912). As active trachoma wanes, conjunctival scarring (TS) becomes 
more apparent; the prevalence of TS increases with age; over 25 years of age, up to 90% of 
people could have conjunctival scarring. (Wright, H.R, Turner, A, & Taylor, H.R, 2008. 
37(9628):1945 – 1954) (Munoz, B, et al., 1999; 1167 – 1171) (Ngondi, J, et al., 
2005.83(12)904 – 912).   While the prevalence of active trachoma is generally similar by 
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sex at young ages, TS and trichiasis (and loss of vision) are generally more common in 
women than in men. (Wright, H.R, Turner, A, &Taylor, H.R, 2008. 37(9628):1945 – 1954) 
(Munoz, B, et al., 1999; 1167 – 1171) (Ngondi, J, et al., 2005.83(12)904 – 912).  (West, S.K, 
et al., 2015: 170 - 175) This difference is attributed to the repeated exposure of women to 
infection because they are more likely than men to care for young children. (Courtright, P, 
& West, S.K, 2004; 20012 - 16)The prevalence of scarring, trichiasis, and corneal opacities 
in older people is predicted by their exposure to trachoma when they were young. This 
concept is important because even when active trachoma has disappeared, the late 
sequelae, including trichiasis, can still occur for decades. (Wright, H.R, Turner, A, &Taylor, 
H.R, 2008. 37(9628):1945 – 1954) (Munoz, B, et al., 1999; 1167 – 1171), (Ngondi, J, et al., 
2005.83(12)904 – 912). Persisting episodes of infection with C trachomatis or other ocular 
infections can contribute to progressive scarring, so reduction of these exposures benefit 
adults. Many cross-sectional and longitudinal studies have linked clean faces to lower risk 
of trachoma. (Silva, M.B.A, et al., 2017:10). Improvement in facial cleanliness also decreases 
the severity of active disease, probably by lowering the likelihood of transmission. (Silva, 
M.B.A, et al., 2017:10). 
Summary and conclusion of the literature review 
The literature review revealed that all prevalence figures for trachoma trichiasis were 
conducted at the country level in few countries as compared to the current available data. It 
was impossible to present some sub analysis in the previous reviews as raw data is not 
used in systemic reviews.  
The primary aim of this thesis was to establish the prevalence of trachoma trichiasis in 
males and females and to assess the age-adjusted odds of trichiasis in women compared to 
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men.  Secondly, sub analysis of specific countries with variable prevalence figures (e.g. 
Nigeria and Ethiopia) was undertaken to understand the association of gender with 
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Abstract  
Trachomatous trichiasis is targeted for elimination by 2020. It is globally accepted that 
there is an excess risk of trachomatous trichiasis in women compared to men with many 
factors contributing to these findings. We sought to update previous work on the subject 
and to undertake some sub-analyses to help interpret the findings. This secondary data 
analysis used data collected through the Global Trachoma Mapping Project (GTMP), a large 
set of standardized population-based trachoma prevalence surveys from 2013-16. Our 
analysis included 693 evaluation units (EUs) in 16 countries with a total sample of 
1,143,742 residents’ age 15 years and above. RevMan V5 was used to generate an age-
adjusted Mantel-Haenszel odds ratio and 95% confidence intervals (CI). Among the 
498,317 men examined 3,566 had trichiasis.  Among the 645,425 women examined 9,156 
women had trichiasis. The overall excess burden of trichiasis in women compared to men 
was 1.87 (95% CI: 1.45, 2.42) while in the 503 EU with a prevalence of trachomatous 
trichiasis ≥ 0.2% (the WHO threshold for elimination) the excess burden of trichiasis in 
women compared to men was 2.01 (95% CI: 1.58 , 2.55). There was considerable 
heterogeneity in the findings at the country level.  Surveys in Ethiopia (24.9% of total 
participants) had an OR of 3.16 (95% CI 2.95, 3.39) while surveys in Nigeria (33.6% of total 
participants) had an  OR of 1.59 (95% CI; 1.50, 1.69). At the EU level we did not find an 
association between the odds of trichiasis in women compared to men according to the 
prevalence of trichiasis. Our findings suggest that gender-specific excess varies 
considerably across Africa; in all settings however efforts are needed to reach women with 
trachoma management services. 
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Background 
Trachoma is the leading infectious cause of blindness worldwide and remains endemic in 
54 countries of the world. (WHO, 2017)  Trachoma is largely found in poor, rural 
communities in low-income countries, particularly in sub-Saharan Africa (Taylor, H, et al 
2014:2142 – 2152) and research has shown that trachoma is associated with poverty, poor 
hygiene, dust, dirty faces, open defecation and poor access to water. (West, S.K, et al., 2015: 
170 – 175). Active trachoma is common in children under the age of 10 years and repeated 
re infection by the causative agent, Chlamydia trachomatis, can lead to scarring of the upper 
tarsal conjunctiva.  Conjunctival scarring can lead to deformation of the lid causing 
entropion (in-turning of the upper eyelid) and trichiasis (eyelashes rubbing the cornea).  
The pathologic process leading from active trachoma to conjunctival scarring to trichiasis is 
gradual; most trichiasis cases are in adults over the age of 40 years. (Solomon, A.W, et al., 
2015: 214 – 225).    Trichiasis can lead to abrasions on the cornea, a painful condition 
which can lead to infections, corneal scarring, and blindness.  The ideal solution is lid 
surgery to re-position the eyelid. (Burton, M, J, 2007: 99 – 116)   
In 2016 it was estimated that there were 2.8 million people in trachoma endemic countries 
with trichiasis, most but not all, due to trachoma.(flueckinger, R.M et al, 2019;364) In the 
same year it was estimated that 260,759 trichiasis surgeries were undertaken globally.  
(WHO Progress report on trachoma 2014 – 2016; 359) 
Analysis of 25 trachoma prevalence surveys in 12 countries before 2009 demonstrated that 
women had an age-adjusted odds of trichiasis 1.82 times (95% CI 1.61-2.07) compared to 
men. (Cromwell, E.A., et al 2009: 985-992)   This meta-analysis included data from 270,972 
people.  We sought to use the epidemiologically robust Global Trachoma Mapping Project 
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(GTMP) data to conduct a similar assessment. Due to the standardized nature of GTMP data 
collection and the size of the GTMP we also sought to undertake a number of sub-analyses, 
not possible with the earlier data sets.   
Methods 
This was a secondary data analysis including data collected through GTMP from 2013 to 
2016.  All GTMP programme countries were invited to submit their trachoma data for this 
analysis.  GTMP was a standardized population-based baseline trachoma prevalence survey 
and GTMP data was collected using the World Health Organization–recommended 
population based prevalence survey methodology. (Solomon, A.W, et al., 2015: 214 – 225). 
Briefly, trachoma suspect districts were identified for inclusion and multi-stage random 
sampling was used in all study sites. Districts which had previously been surveyed were 
not included in this analysis. For each evaluation unit (EU), generally an administrative 
district of around 100,000-250,000 people, between 20-30 clusters (villages) were 
randomly selected using population proportional to size sampling.  In each cluster 
approximately 30 households (depending on household size) were randomly selected, 
either using household lists or using compact segment sampling, when household lists 
were not available. The estimated sample size requirement per EU was based on an 
expected TF prevalence of 10% in children aged 1–9 years, a design effect of 2.65, and a 
desire to be 95% confident of estimating the TF prevalence with 3% absolute precision. 
(Solomon, A.W, et al., 2015: 214 – 225). 
  Study participant enrollment was done door-to-door with all residents in a sampled 
household age 1 year and above invited for examination after informed consent was 
requested.  Examination entailed assessment, by a trained and certified grader, of the 
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presence of TF, trachomatous inflammation: intense (TI), and trichiasis.  Trichiasis was 
defined as one or more lash touching the globe or evidence of recent epilation.  No 
assessment of trachomatous conjunctival scarring was undertaken as part of GTMP until 
2015.  For the purpose of our study, we defined trichiasis as with or without conjunctival 
scarring.  Data was collected on android phones using a purpose-built app through a LINKS 
application.  Data was uploaded to the server, checked for accuracy and standard reporting 
files were prepared.       
To obtain data for this analysis, GTMP requested authorization from all participating 
national Ministries of Health.  Data from countries agreeing to participate was received in a 
CSV format.     
Sex specific age adjusted prevalence of trichiasis was calculated for all EUs as each EU is an 
independent data set.  RevMan 5, meta-analysis software (RevMan V5, 2014) was used to 
conduct the overall assessment of female excess of trichiasis.  Findings were generated 
using Mantel-Haenszel (M-H) pooled random effect odds ratios (OR) and 95% confidence 
intervals (CI).  A measure of heterogeneity of the data is also generated.  RevMan 5 also 
generated forest plots, a graphic display of the findings.    Data was then pooled by country 
and similar odds ratios and 95% CI calculated.   
As the WHO threshold for elimination of trichiasis as a public health problem in an EU is a 
prevalence of unmanaged trachomatous trichiasis of <0.2% among the age group 15 years 
and above (WHO Progress report on elimination of trachoma 2014 -2016; 359) we 
undertook an additional assessment of EUs with a prevalence of trichiasis ≥0.2%.  This 
decision was made as public health interventions are only recommended when trichiasis is 
≥0.2% in the adult population.  When the prevalence is below this threshold, it is expected 
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that routine clinical services will be responsible for management of the rare condition. 
Given the size of the data sets from Ethiopia and Nigeria, data was pooled by region/state 
to assess heterogeneity within the countries. 
Finally, we also used the data to explore whether the relationship between men and 
women (the odds ratios) were similar in different bands of trichiasis endemicity (age and 
sex adjusted EU level trichiasis prevalence).  Age and sex adjusted trichiasis prevalence 
bands of 0.20% were generated from the data, starting with the prevalence of 0.20-0.39%. 
and mean OR for each band was calculated to assess if there was an association between 
the prevalence of trichiasis and gender-specific excess.   
Ethical approval for GTMP was provided by the London School for Hygiene & Tropical 
Medicine (reference 6319) and the national level ethics committee in each country.  Ethical 
approval for this secondary analysis was obtained by the Human Research Committee of 
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Results 
Among the 693 EUs in 16 countries for which data was received (Table 1) there were 
498,317 men and 645,425 women examined.  There were 503 EUs (72.6%) that had 
trichiasis prevalence above the WHO threshold for elimination. 









#EU with a trichiasis 
prevalence≥0.2%.  (% of 
total EU) 
Benin 11 7655 12140 19795 7 (63.6) 
Cambodia 14 19268 21812 41080 3 (21.4) 
Cote d’Ivoire 10 8147 10712 18859                    3 (30.0) 
DR Congo 44 23708 33127 56835 42 (95.5) 
Egypt 4 2583 3446 6029                   4 (100) 
Ethiopia 170 129885 154730 284615      164 (96.5) 
Guinea 14 9189 13167 22356  6 (42.9) 
Malawi 24 13475 22975 36450    17 (70.8) 
Mozambique 82 49022 66656 115678     40 (48.8) 
Nigeria 220 167094 217140 384234        168 (76.4) 
Solomon Islands 3 2309 3155 5464  1 (33.3) 
Sudan 32 15620 25427 41047       21(65.6) 
Tanzania 19 17245 22656 39901     14 (73.7) 
Uganda 4 3252 4390 7642                      2 (50.0) 
Vanuatu 1 1225 1286 2511                      0 (0) 
Yemen 41 28640 32606 61246      11 (26.8) 
Total                    693 498317 645425 1143742                    503 (72.6)  
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The 16 countries in this analysis were primarily from sub-Saharan African (SSA); the five 
countries from outside of SSA (Yemen, Vanuatu, Solomon Islands, Egypt and Cambodia) 
contributed 10.27% of the study population.   Ethiopia contributed 24.9% of the study 
population and Nigeria contributed 33.6% of the study population.  
There were 12,722 people (9,156 women and  3,566 men) with trichiasis.   Pooling all data 
from the 693 EU the overall M-H OR of females to males with trichiasis was 1.99 (95% CI: 
1.54, 2.89) [forest plot too large to present].  Pooling all data at country level and creating a 
forest plot for the data at the country-level provides an M-H OR of 1.87 (95% CI 1.45, 2.42). 
[Figure 1] 




















Heterogeneity: Tau² = 0.20; Chi² = 361.32, df = 15 (P < 0.00001); I² = 96%
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Among the 16 countries represented 11 (68.8%) had a M-H OR and CI that exceeded 1; the 
other five countries (Vanuatu, Solomon Islands, Guinea, Cote d’Ivoire, and Benin) only 
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contributed 383 (3%) trichiasis cases to the analysis.  The M-H OR for Nigeria was 1.59 
(95% CI 1.50-1.69), significantly less than the M-H OR for Ethiopia (OR 3.16, 95% CI 2.95, 
3.39).  Heterogeneity was significant (p<0.001)  
There were 503 EU with a trichiasis prevalence ≥0.2% and the M-H pooled OR in these EU 
was  2.01 (95% CI: 1.58 , 2.55) .  Removing EU with trichiasis <0.2% reduced the survey 
population of women from 645,425 to 466,812 (72.3%) and of men from 498,317 to 
358,698 (72.0%) while only reducing the number of women with trichiasis from 9,156 to 
9,007 (98.4%) and of men with trichiasis from 3,566 to 3,494 (98.0%). Country level 
grouping of OR revealed an M-H OR of 1.91 (95% CI 1.46-2.48). (Figure 2)   Heterogenity of 
data remained significant. (p<0.001) 
Figure 2: Forest plot presenting the M - H Odds ratios for the 15 Countries with 




















Heterogeneity: Tau² = 0.20; Chi² = 352.97, df = 14 (P < 0.00001); I² = 96%
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The size of the data sets from Nigeria and Ethiopia as well as the significant difference in 
their respective M-H OR led to a sub-analysis of state/regional level data from both 
countries. We limited the sub-analysis to EU with a trichiasis prevalence ≥0.2%.  The 
overall M-H OR for Ethiopia was 3.17 (95% CI 2.95-3.40).  Compiling the data region by 
region provided a M-H OR of 2.95 (95% CI: 2.46, 3.55); all 7 regions in Ethiopia showed M-
H OR above 2.2 and there was overlap in all of the confidence intervals. (Figure 3)  Even 
with all regions having a relatively high OR, there was considerable heterogeneity of 
findings. 











Heterogeneity: Tau² = 0.04; Chi² = 29.99, df = 6 (P < 0.0001); I² = 80%
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One hundred and sixty eight EUs in Nigeria had a trichiasis prevalence ≥0.2% and the 
overall excess M-H OR of trichiasis in women to men was 1.59 (95% CI: 1.49-1.68).   
Compiling the OR at the state level revealed the same M-H OR of 1.59 (95% CI: 1.46-1.73). 
(Fig. 4). There was little heterogeneity in the findings summarized at the state level. 
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Figure 4; Forest Plot for all the GTMP Evaluation Units with WHO prevalence 

















Heterogeneity: Tau² = 0.01; Chi² = 17.06, df = 12 (P = 0.15); I² = 30%
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There were 15 age and sex adjusted trichiasis prevalence bands of 0.20%, starting with the 
prevalence of 0.20-0.39% and ending with a prevalence of 3.0% or more.  In 254 of the 503 
EU (50.5%) the age-sex adjusted prevalence of trichiasis was <1% and in only 72 EU 
(14.3%) was it 3% or more.  There was no relationship between the age and sex- adjusted 
prevalence of trichiasis and the OR within each prevalence bands. (Table 2)  The 
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Table 2: Association between baseline age-sex adjusted prevalence of trichiasis and mean odds 
of female excess 
Trichiasis 
prevalence category 
Global mean  
odds ratio 
Rest of the World 







0.20-0.39 1.79 1.64 1.52 1.93 
0.40-0.59 2.78 2.37 3.71 2.27 
0.60-0.79 4.26 3.95 7.00 1.85 
0.80-0.99 3.23 3.79 3.73 2.43 
1.00-1.19 1.85 1.98 2.10 1.36 
1.20-1.39 3.08 2.54 4.23 2.92 
1.40-1.59 2.79 2.03 5.30 1.52 
1.60-1.79 3.40 4.15 3.69 1.82 
1.80-1.99 2.44 1.61 4.32 1.31 
2.00-2.19 2.97 1.63 6.03 1.63 
2.20-2.39 3.58 0.72 7.14 2.88 
2.40-2.59 4.33 2.97 8.81 1.23 
2.60-2.79 2.82 2.58 3.61 2.33 
2.80-2.99 1.88 0.46 3.6 1.51 
3.00-above 2.08 1.24 3.31 1.65 
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Discussion 
Trichiasis remains a public health problem in many countries of sub-Saharan Africa and the 
Middle East and over 2.5 million people will need management of trichiasis to prevent 
corneal opacities and vision loss.  In 2009 it was estimated that the excess burden of 
trichiasis in women compared to men of 1.82 (95% CI 1.61—2.07). (Cromwell, E.A., et al 
2009: 985-992)  Due to limited data available, the systematic review could not be used to 
conduct further sub analysis.  The findings from the GTMP data are similar to the earlier 
results, with an excess prevalence slightly higher than the previous work.  Limiting our 
analysis to only EU with trichiasis prevalence above the WHO threshold for elimination 
made little change to the overall findings.   
Country-specific analyses revealed that there was considerable variation in the OR 
country by country.  The number of EU included for each country varied hugely limiting our 
ability to compare findings from a number of the countries.  Nevertheless, the findings from 
the two largest countries in the analysis, Nigeria and Ethiopia suggest that there may be 
country-specific reasons for the gender differences.  We can provide no explanation, at the 
present time, why Ethiopian EUs would have higher female to male OR compared to the 
Nigerian EUs.  Possible explanations that deserve investigation include the potential 
contribution of household family size, clustering of trachoma within households and 
communities, cultural factors (e.g., difference in interactions between adult women and 
children), and religious factors (e.g., how well do women mix with men at household and at 
community level).  It appears, however, that trichiasis prevalence is not a predictor for 
female excess of trichiasis.      
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Whether including data from all countries or limiting the analysis to Nigeria or Ethiopia we 
found no association between the prevalence of trichiasis in an EU and the excess burden of 
trichiasis in women as expressed by the M-H OR. This is contrary to findings, recently 
reported from GTMP surveys in Chad in which a higher prevalence of trichiasis was 
associated to the excess burden of trichiasis in women. (Dezoumbe, et al., 2018) Further 
investigation is warranted. 
While the GTMP data used in this analysis is large, the rarity of trichiasis in each of the 
survey units means that the variation around the prevalence estimate, generally expressed 
as a standard error, is quite large.  This implies that the analysis of mean OR for each of the 
prevalence bands can also have significant variation around the OR.  The M-H OR generated 
by RevMan accounts for small sample sizes, generating a robust overall estimate of female 
excess of trichiasis compared to men.  While this analysis includes many trachoma endemic 
countries, it does not include all trachoma endemic countries.  It is possible that the 
findings from countries, not included in this analysis, would be substantially different.     
From a programmatic perspective, the findings indicate that countries would be well-
placed to assess the excess of trichiasis in women compared to men and ensure that all of 
those with trichiasis are receiving access to trichiasis management. Programmes should 
monitor the gender-specific uptake of trichiasis surgery to ensure that no group is 
particularly disadvantaged.  As impact and surveillance surveys become more 
commonplace it would be important to assess if gender specific excess remains the norm or 
if programmes have successfully reached women.  Past work in Egypt (MousaA, courtright, 
P, Kazanjian, A & basset, K2014; 190 - 196) showed that women were still less likely to 
access trichiasis surgery compared to men while research in Tanzania (West, S, et al 
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2004;88:1368- 1371) suggested that there was no difference in gender-specific access.  
Additional research on gender-specific access of trichiasis services is needed. 
Finally, the results, when compared against programme services (country by country) may 
help governments and NGO partners to assess whether they are reaching gender equity in 
terms of their services.    
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Appendix 2: Expression of Interest (EoI) to tender 
PROJECT TITLE: Global Trachoma Mapping Project: 
secondary analyses  
 
Expression of Interest (EoI) to tender 
Part A: Organisation and contact details 
 
1. ORGANISATION DETAILS 
1a Enter the full name of the organisation 
submitting EoI.  
 
Kilimanjaro Centre for 
Community Ophthalmology, 
University of Cape Town 
1b Registered office address  
Rm 25, H-53, OMB 
Groote Schuur Hospital 
Observatory, 7925 
South Africa 
1c If this is a consortium submission, please 
enter the names of the other organisations here. 
 
 
2. CONTACT PERSON 
Contact details for enquiries  
(one contact point only) 
2a Name Paul Courtright 
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2b Address 
Rm 25, H-53, OMB 
Groote Schuur Hospital 
Observatory, 7925 
South Africa 
2c Daytime phone number +27-21-6712266 
2d Mobile number +27-726772762 
2e Email pcourtright@kcco.net 
 
 
(You may expand the boxes for Parts B and C so that they occupy no more than 2 
A4 pages). 
PART B – Project description 
 
3a Research question  What is the excess burden of TT in women compared 
to men? 
 Does the ratio of women to men vary at different 
prevalences of TT?  
 Is the ratio the same in all trachoma endemic 
countries? If not, what might explain the differences? 
  
This question was addressed in the paper by Cromwell et al.  
using existing TT data.  This should be repeated with the 
large and varied data set available from GTMP. 
 
3b Methodology All data will be compiled in 5 year age groups prior to 
calculating differences between men and women; as women 
often live longer than men data will also be standardized to 
the age distribution of men and women in the country.  All 
baseline GTMP data will be requested.  Impact assessment 
data will not be used as there may be differences in 
utilization between men and women.  A pooled age-adjusted 
gender-excess will be calculated.  Sub-group analyses will 
include assessment of gender-excess at different levels of 
TT prevalence as well as regions or countries in the world.   
 
Stata (12) statistical software will be used for analytic 
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purposes. This project will be carried out by George 
Moyo, a Malawian MPH student at UCT as part of his 
dissertation.  He will be supervised by Paul Courtright, 
Robert Geneau, and his UCT faculty. 
3c Expected outcomes  
 
The expected outcomes of this work will include a publication of 
the findings and dissemination to all national programmes.  The 
information generated by this work will be of value for advocacy 
at the national and the global level.  
  
 
PART C – Experience and financial standing  
 
4a Experience KCCO has experience in data analysis, research planning, 
supervision of students, and all aspects of trichiasis.  The 
student, Mr. Moyo is taking courses in epidemiology and 
biostatistics, including the use of Stata.  He will be 
supported throughout the research process.   
4b Resources available to 
undertake the work 
Research supervision by Paul Courtright and Robert 
Geneau.  There is no need for travel costs, space, or 
equipment for this work.  KCCO will provide costs 
associated with internet access, secretarial support, and 
office supplies 
4c Resources requested  
(please note that only 
limited resources for 
publication and 
dissemination of project 
results can be requested) 
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